iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Lupin’s Swiss unit to acquire established product portfolio from Sanofi

22 Dec 2023 , 11:07 PM

Lupin Ltd stated on Friday that its wholly-owned subsidiary in Switzerland will purchase Sanofi PLC’s portfolio of accretive established pharmaceuticals in Europe.

Lupin Atlantis Holdings SA, Switzerland (LAHSA), a subsidiary of pharma giant Lupin, inked an ‘Asset Purchase Agreement’ with the French multinational pharmaceutical and healthcare firm Sanofi to purchase a portfolio of accretive established products in Europe and Canada.

AARANE in Germany and NALCROM in Canada and the Netherlands are among the brands bought by Lupin Atlantis Holdings SA, Switzerland, from Sanofi.

The acquisition of the two brands costs 10 million euros (about Rs 91 crore), plus sales milestones of up to 8 million euros (around Rs 72.8 crore), depending on future sales. The corporation told the exchanges that the transaction would be conducted in cash.

Lupin is acquiring these brands as part of a strategic interest in bringing accretive assets in the respiratory field to help structure the company’s new respiratory franchise in Germany, following the launch of Luforbec and Gx Spiriva, as well as the acquisition of the brands Xopenex and Brovana in the United States.

The purchase is subject to Foreign Direct Investment Bureau of Canada clearance and is scheduled to be finalised by the first quarter of 2024.

Lupin’s counter settled with a gain of 0.65% at Rs 1,265 per piece on NSE.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Lupin
  • Lupin News
  • Lupin Swiss Arm
  • Lupin Updates
  • Sanofi
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.